Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Sarcopenia | 13 | 2022 | 53 | 6.970 |
Why?
|
Tomography, X-Ray Computed | 34 | 2022 | 871 | 5.250 |
Why?
|
Bone Density | 31 | 2021 | 182 | 5.160 |
Why?
|
Osteoporosis | 19 | 2021 | 51 | 4.660 |
Why?
|
Absorptiometry, Photon | 24 | 2019 | 129 | 2.630 |
Why?
|
Magnetic Resonance Imaging | 37 | 2022 | 1219 | 2.400 |
Why?
|
Radiology | 10 | 2019 | 37 | 2.260 |
Why?
|
Diabetes Mellitus, Type 2 | 15 | 2019 | 1379 | 1.700 |
Why?
|
Psoas Muscles | 4 | 2019 | 19 | 1.650 |
Why?
|
Humans | 133 | 2022 | 29123 | 1.480 |
Why?
|
Algorithms | 5 | 2019 | 462 | 1.310 |
Why?
|
Tendons | 11 | 2019 | 57 | 1.160 |
Why?
|
Spinal Fractures | 4 | 2018 | 42 | 1.070 |
Why?
|
Fractures, Bone | 4 | 2020 | 149 | 1.020 |
Why?
|
Body Composition | 14 | 2021 | 365 | 0.940 |
Why?
|
Aged | 41 | 2022 | 9492 | 0.910 |
Why?
|
Muscle, Skeletal | 8 | 2021 | 494 | 0.900 |
Why?
|
Bone Diseases, Metabolic | 2 | 2019 | 20 | 0.880 |
Why?
|
Female | 68 | 2020 | 18173 | 0.870 |
Why?
|
Ankle Joint | 5 | 2019 | 34 | 0.860 |
Why?
|
Male | 63 | 2020 | 17815 | 0.850 |
Why?
|
Middle Aged | 52 | 2020 | 10834 | 0.830 |
Why?
|
Weight Loss | 10 | 2019 | 413 | 0.790 |
Why?
|
Accidents, Traffic | 2 | 2020 | 190 | 0.760 |
Why?
|
Research | 3 | 2017 | 72 | 0.740 |
Why?
|
Spine | 8 | 2021 | 38 | 0.740 |
Why?
|
Diagnostic Imaging | 7 | 2019 | 88 | 0.740 |
Why?
|
Bone and Bones | 6 | 2018 | 87 | 0.730 |
Why?
|
Adipose Tissue | 7 | 2019 | 327 | 0.730 |
Why?
|
Obesity | 13 | 2019 | 1063 | 0.710 |
Why?
|
African Americans | 7 | 2018 | 1373 | 0.700 |
Why?
|
Injury Severity Score | 1 | 2019 | 115 | 0.700 |
Why?
|
Molecular Probe Techniques | 2 | 2015 | 4 | 0.640 |
Why?
|
Molecular Diagnostic Techniques | 2 | 2015 | 9 | 0.640 |
Why?
|
Knee Joint | 10 | 2017 | 129 | 0.640 |
Why?
|
Molecular Probes | 2 | 2015 | 15 | 0.640 |
Why?
|
Radius | 1 | 2017 | 21 | 0.630 |
Why?
|
Molecular Imaging | 2 | 2015 | 22 | 0.630 |
Why?
|
Osteoporosis, Postmenopausal | 3 | 2004 | 10 | 0.600 |
Why?
|
Hip Fractures | 1 | 2017 | 30 | 0.600 |
Why?
|
Mortality | 1 | 2017 | 109 | 0.590 |
Why?
|
Survival Analysis | 2 | 2018 | 440 | 0.580 |
Why?
|
Image Interpretation, Computer-Assisted | 2 | 2015 | 113 | 0.580 |
Why?
|
Lumbar Vertebrae | 7 | 2022 | 98 | 0.570 |
Why?
|
Thoracic Vertebrae | 3 | 2018 | 42 | 0.550 |
Why?
|
European Continental Ancestry Group | 5 | 2019 | 1131 | 0.540 |
Why?
|
Societies, Medical | 8 | 2021 | 149 | 0.490 |
Why?
|
Exercise | 8 | 2018 | 592 | 0.490 |
Why?
|
Aged, 80 and over | 20 | 2019 | 3719 | 0.480 |
Why?
|
Mass Screening | 3 | 2020 | 223 | 0.450 |
Why?
|
Reproducibility of Results | 9 | 2021 | 726 | 0.420 |
Why?
|
Soft Tissue Neoplasms | 3 | 2018 | 35 | 0.410 |
Why?
|
United States | 11 | 2021 | 3632 | 0.410 |
Why?
|
Sensitivity and Specificity | 11 | 2019 | 532 | 0.390 |
Why?
|
Prevalence | 5 | 2020 | 898 | 0.370 |
Why?
|
Ultrasonography | 9 | 2018 | 347 | 0.370 |
Why?
|
Adult | 31 | 2019 | 8426 | 0.370 |
Why?
|
Evidence-Based Medicine | 6 | 2021 | 207 | 0.370 |
Why?
|
Pelvic Bones | 4 | 2016 | 31 | 0.350 |
Why?
|
Tibia | 3 | 2014 | 56 | 0.350 |
Why?
|
Organ Size | 3 | 2019 | 196 | 0.340 |
Why?
|
Diet, Reducing | 5 | 2009 | 90 | 0.340 |
Why?
|
Synovial Fluid | 2 | 2019 | 7 | 0.340 |
Why?
|
Wrist Injuries | 2 | 2019 | 36 | 0.340 |
Why?
|
Osteomyelitis | 2 | 2019 | 22 | 0.330 |
Why?
|
Sex Factors | 4 | 2019 | 631 | 0.320 |
Why?
|
Retrospective Studies | 13 | 2020 | 3112 | 0.320 |
Why?
|
Densitometry | 3 | 2002 | 8 | 0.310 |
Why?
|
Joint Diseases | 5 | 2017 | 33 | 0.300 |
Why?
|
Foot | 2 | 2018 | 40 | 0.300 |
Why?
|
Wrist | 3 | 2020 | 39 | 0.290 |
Why?
|
Heart | 5 | 2009 | 162 | 0.290 |
Why?
|
Proportional Hazards Models | 2 | 2019 | 709 | 0.280 |
Why?
|
Ligaments, Articular | 5 | 2019 | 39 | 0.280 |
Why?
|
Contrast Media | 5 | 2019 | 124 | 0.280 |
Why?
|
Trauma Severity Indices | 2 | 2015 | 51 | 0.270 |
Why?
|
Diagnostic Errors | 2 | 2015 | 42 | 0.270 |
Why?
|
Tendon Injuries | 3 | 2015 | 36 | 0.260 |
Why?
|
Osteoarthritis, Knee | 2 | 2021 | 80 | 0.260 |
Why?
|
Collateral Ligaments | 2 | 2014 | 9 | 0.260 |
Why?
|
Inheritance Patterns | 1 | 2004 | 10 | 0.250 |
Why?
|
Cartilage, Articular | 3 | 2021 | 68 | 0.250 |
Why?
|
Bone Diseases | 3 | 2019 | 16 | 0.250 |
Why?
|
Risk Factors | 5 | 2019 | 3537 | 0.250 |
Why?
|
Age Factors | 2 | 2019 | 1108 | 0.250 |
Why?
|
Registries | 2 | 2015 | 278 | 0.240 |
Why?
|
Knee | 2 | 2021 | 31 | 0.240 |
Why?
|
Osteochondritis Dissecans | 2 | 2000 | 12 | 0.240 |
Why?
|
Radiography, Abdominal | 2 | 2019 | 16 | 0.240 |
Why?
|
Menisci, Tibial | 4 | 2000 | 24 | 0.230 |
Why?
|
Radiography | 5 | 2016 | 353 | 0.230 |
Why?
|
Aging | 4 | 2019 | 881 | 0.230 |
Why?
|
Chondrocalcinosis | 2 | 2020 | 2 | 0.230 |
Why?
|
Motor Vehicles | 2 | 2020 | 22 | 0.220 |
Why?
|
Diagnosis, Differential | 10 | 2018 | 493 | 0.220 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2003 | 100 | 0.220 |
Why?
|
Proteins | 1 | 2003 | 140 | 0.220 |
Why?
|
Lumbosacral Region | 1 | 2022 | 12 | 0.220 |
Why?
|
Body Mass Index | 8 | 2015 | 865 | 0.210 |
Why?
|
Space Flight | 1 | 2022 | 19 | 0.210 |
Why?
|
Fingers | 2 | 2015 | 57 | 0.200 |
Why?
|
Cadaver | 9 | 2019 | 143 | 0.200 |
Why?
|
Practice Guidelines as Topic | 3 | 2019 | 374 | 0.200 |
Why?
|
Femur Neck | 2 | 2017 | 19 | 0.200 |
Why?
|
Medical Records | 2 | 2017 | 68 | 0.200 |
Why?
|
Ribs | 2 | 2016 | 40 | 0.190 |
Why?
|
Databases, Factual | 2 | 2019 | 332 | 0.190 |
Why?
|
Prognosis | 3 | 2019 | 1362 | 0.190 |
Why?
|
Phantoms, Imaging | 1 | 2020 | 56 | 0.190 |
Why?
|
Cartilage Diseases | 2 | 2019 | 20 | 0.180 |
Why?
|
Metatarsalgia | 1 | 2019 | 1 | 0.180 |
Why?
|
Toes | 1 | 2019 | 16 | 0.180 |
Why?
|
Sarcoma | 1 | 2020 | 56 | 0.180 |
Why?
|
Consensus Development Conferences as Topic | 1 | 2019 | 9 | 0.180 |
Why?
|
Esophageal Neoplasms | 1 | 2019 | 33 | 0.180 |
Why?
|
Diabetic Foot | 1 | 2019 | 19 | 0.180 |
Why?
|
Abdominal Muscles | 1 | 2019 | 6 | 0.180 |
Why?
|
Pubic Symphysis | 1 | 2019 | 4 | 0.180 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 2019 | 56 | 0.180 |
Why?
|
Automation | 1 | 2019 | 30 | 0.180 |
Why?
|
Radiology Information Systems | 2 | 2017 | 13 | 0.180 |
Why?
|
Ankle | 2 | 2018 | 22 | 0.180 |
Why?
|
Forensic Medicine | 1 | 2019 | 14 | 0.180 |
Why?
|
Cardiovascular Diseases | 3 | 2018 | 1017 | 0.170 |
Why?
|
Knee Injuries | 3 | 2017 | 39 | 0.170 |
Why?
|
Terminology as Topic | 1 | 2019 | 62 | 0.170 |
Why?
|
Autopsy | 1 | 2019 | 37 | 0.170 |
Why?
|
Radiopharmaceuticals | 1 | 2019 | 88 | 0.170 |
Why?
|
Burnout, Professional | 1 | 2020 | 44 | 0.170 |
Why?
|
Radiation Dosage | 1 | 2019 | 72 | 0.170 |
Why?
|
Quality Assurance, Health Care | 1 | 2019 | 61 | 0.170 |
Why?
|
Hand Injuries | 1 | 2019 | 24 | 0.170 |
Why?
|
Wrist Joint | 1 | 2019 | 47 | 0.170 |
Why?
|
Follow-Up Studies | 3 | 2019 | 2109 | 0.170 |
Why?
|
Longitudinal Studies | 2 | 2018 | 721 | 0.170 |
Why?
|
Adiponectin | 2 | 2013 | 103 | 0.170 |
Why?
|
Metatarsophalangeal Joint | 1 | 2018 | 5 | 0.170 |
Why?
|
Hallux | 1 | 2018 | 5 | 0.160 |
Why?
|
Compressive Strength | 1 | 2018 | 20 | 0.160 |
Why?
|
Shoulder Pain | 1 | 2018 | 10 | 0.160 |
Why?
|
Comorbidity | 2 | 2017 | 540 | 0.160 |
Why?
|
Foot Joints | 1 | 2017 | 3 | 0.160 |
Why?
|
Elbow Joint | 2 | 2014 | 53 | 0.160 |
Why?
|
Lower Extremity | 2 | 2018 | 94 | 0.160 |
Why?
|
Medicare | 1 | 2019 | 186 | 0.160 |
Why?
|
Causality | 1 | 2017 | 37 | 0.150 |
Why?
|
Calcinosis | 3 | 2016 | 143 | 0.150 |
Why?
|
California | 1 | 2017 | 60 | 0.150 |
Why?
|
Patellofemoral Joint | 1 | 2017 | 14 | 0.150 |
Why?
|
Education, Medical | 1 | 2017 | 67 | 0.150 |
Why?
|
Patient Care Planning | 1 | 2017 | 53 | 0.150 |
Why?
|
Resistance Training | 1 | 2017 | 70 | 0.150 |
Why?
|
Predictive Value of Tests | 1 | 2019 | 787 | 0.150 |
Why?
|
Adenocarcinoma | 1 | 2019 | 301 | 0.150 |
Why?
|
Nerve Compression Syndromes | 2 | 2015 | 8 | 0.150 |
Why?
|
Atherosclerosis | 2 | 2016 | 698 | 0.150 |
Why?
|
Sternoclavicular Joint | 1 | 2016 | 4 | 0.140 |
Why?
|
Popliteal Cyst | 1 | 1996 | 1 | 0.140 |
Why?
|
Sternum | 1 | 2016 | 13 | 0.140 |
Why?
|
Pain | 1 | 2019 | 282 | 0.140 |
Why?
|
Clavicle | 1 | 2016 | 15 | 0.140 |
Why?
|
Lipoma | 1 | 2016 | 8 | 0.140 |
Why?
|
Osteosclerosis | 1 | 2016 | 1 | 0.140 |
Why?
|
Bone Diseases, Developmental | 1 | 2016 | 2 | 0.140 |
Why?
|
Medical Oncology | 1 | 2017 | 70 | 0.140 |
Why?
|
North Carolina | 2 | 2018 | 1423 | 0.140 |
Why?
|
Aortic Diseases | 1 | 2016 | 54 | 0.140 |
Why?
|
Carotid Artery Diseases | 1 | 2016 | 109 | 0.130 |
Why?
|
Tomography, Spiral Computed | 2 | 2006 | 18 | 0.130 |
Why?
|
Ligaments | 1 | 2015 | 12 | 0.130 |
Why?
|
Coronary Vessels | 1 | 2016 | 147 | 0.130 |
Why?
|
Finger Injuries | 1 | 2015 | 7 | 0.130 |
Why?
|
Anti-Bacterial Agents | 1 | 2018 | 285 | 0.130 |
Why?
|
Fractures, Stress | 1 | 2015 | 11 | 0.130 |
Why?
|
Femoral Fractures | 1 | 2015 | 39 | 0.130 |
Why?
|
Soft Tissue Injuries | 1 | 2014 | 27 | 0.130 |
Why?
|
Patient-Centered Care | 1 | 2015 | 68 | 0.130 |
Why?
|
Functional Laterality | 1 | 2014 | 59 | 0.130 |
Why?
|
Evaluation Studies as Topic | 1 | 2014 | 39 | 0.130 |
Why?
|
Hip | 3 | 2003 | 13 | 0.120 |
Why?
|
Disease Progression | 1 | 2016 | 572 | 0.120 |
Why?
|
Psoas Abscess | 1 | 1994 | 1 | 0.120 |
Why?
|
Hematoma | 1 | 1994 | 23 | 0.120 |
Why?
|
Fibroma | 1 | 2013 | 11 | 0.120 |
Why?
|
Models, Anatomic | 1 | 2014 | 38 | 0.120 |
Why?
|
Life Style | 2 | 2014 | 364 | 0.120 |
Why?
|
Adolescent | 7 | 2016 | 3255 | 0.110 |
Why?
|
Gait | 1 | 2014 | 115 | 0.110 |
Why?
|
Physical Fitness | 1 | 2014 | 119 | 0.110 |
Why?
|
Young Adult | 5 | 2019 | 2402 | 0.110 |
Why?
|
C-Reactive Protein | 3 | 2013 | 232 | 0.110 |
Why?
|
Mobility Limitation | 1 | 2014 | 187 | 0.110 |
Why?
|
Diabetic Angiopathies | 1 | 2013 | 137 | 0.110 |
Why?
|
Image Processing, Computer-Assisted | 3 | 2017 | 242 | 0.110 |
Why?
|
Adiposity | 1 | 2013 | 191 | 0.100 |
Why?
|
Risk Assessment | 1 | 2017 | 1306 | 0.100 |
Why?
|
Energy Intake | 2 | 2009 | 120 | 0.100 |
Why?
|
Sarcoma, Synovial | 1 | 1991 | 6 | 0.100 |
Why?
|
Hemangioma | 1 | 1991 | 18 | 0.100 |
Why?
|
Exercise Therapy | 2 | 2019 | 229 | 0.100 |
Why?
|
Genetic Predisposition to Disease | 3 | 2016 | 836 | 0.090 |
Why?
|
Joint Capsule | 2 | 2000 | 7 | 0.090 |
Why?
|
Bone Morphogenetic Protein 7 | 1 | 2009 | 18 | 0.090 |
Why?
|
Forearm | 2 | 2014 | 33 | 0.090 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 2 | 2019 | 22 | 0.090 |
Why?
|
Blood Vessels | 1 | 2009 | 47 | 0.090 |
Why?
|
Postmenopause | 5 | 2009 | 397 | 0.090 |
Why?
|
Severity of Illness Index | 3 | 2019 | 863 | 0.080 |
Why?
|
Abdominal Fat | 1 | 2009 | 46 | 0.080 |
Why?
|
Imaging, Three-Dimensional | 2 | 2006 | 130 | 0.080 |
Why?
|
Neoplasms | 2 | 1997 | 611 | 0.080 |
Why?
|
Dietary Proteins | 1 | 2008 | 50 | 0.080 |
Why?
|
Energy Metabolism | 1 | 2009 | 139 | 0.080 |
Why?
|
Sex Characteristics | 4 | 2013 | 167 | 0.080 |
Why?
|
Archaeology | 1 | 2006 | 1 | 0.070 |
Why?
|
Cooking and Eating Utensils | 1 | 2006 | 1 | 0.070 |
Why?
|
Alloys | 1 | 2006 | 2 | 0.070 |
Why?
|
Soil | 1 | 2006 | 4 | 0.070 |
Why?
|
Copper | 1 | 2006 | 11 | 0.070 |
Why?
|
Radiographic Image Enhancement | 1 | 2006 | 30 | 0.070 |
Why?
|
Animals | 2 | 2015 | 7299 | 0.070 |
Why?
|
Adipocytes | 1 | 2006 | 79 | 0.070 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2009 | 1079 | 0.070 |
Why?
|
Estrogen Replacement Therapy | 1 | 2006 | 182 | 0.070 |
Why?
|
Cross-Sectional Studies | 3 | 2018 | 1362 | 0.060 |
Why?
|
Intercellular Adhesion Molecule-1 | 1 | 2004 | 41 | 0.060 |
Why?
|
Fractures, Spontaneous | 2 | 2002 | 14 | 0.060 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2005 | 134 | 0.060 |
Why?
|
Nuclear Family | 1 | 2004 | 15 | 0.060 |
Why?
|
Radiography, Thoracic | 1 | 2004 | 43 | 0.060 |
Why?
|
Patella | 3 | 2000 | 19 | 0.060 |
Why?
|
Rib Fractures | 1 | 2004 | 20 | 0.060 |
Why?
|
Receptors, Leptin | 1 | 2003 | 6 | 0.060 |
Why?
|
Leptin | 1 | 2003 | 66 | 0.060 |
Why?
|
Receptors, Cell Surface | 1 | 2003 | 72 | 0.060 |
Why?
|
Bone Neoplasms | 2 | 2002 | 104 | 0.060 |
Why?
|
Arthroscopy | 2 | 2007 | 199 | 0.060 |
Why?
|
Inflammation | 1 | 2005 | 507 | 0.050 |
Why?
|
Confidence Intervals | 1 | 2002 | 140 | 0.050 |
Why?
|
Back Pain | 1 | 2021 | 28 | 0.050 |
Why?
|
Patellar Ligament | 2 | 2000 | 6 | 0.050 |
Why?
|
Monitoring, Physiologic | 1 | 2002 | 68 | 0.050 |
Why?
|
Combined Modality Therapy | 3 | 2008 | 525 | 0.050 |
Why?
|
Alendronate | 1 | 2001 | 12 | 0.050 |
Why?
|
Continuity of Patient Care | 1 | 2002 | 64 | 0.050 |
Why?
|
Joint Loose Bodies | 1 | 2000 | 4 | 0.050 |
Why?
|
Selective Estrogen Receptor Modulators | 1 | 2001 | 29 | 0.050 |
Why?
|
Tarsal Bones | 1 | 2000 | 5 | 0.050 |
Why?
|
Temporomandibular Joint | 1 | 2020 | 3 | 0.050 |
Why?
|
Accreditation | 1 | 2020 | 14 | 0.050 |
Why?
|
Diet, Sodium-Restricted | 1 | 2000 | 20 | 0.050 |
Why?
|
Data Interpretation, Statistical | 1 | 2001 | 103 | 0.050 |
Why?
|
Extremities | 1 | 2020 | 48 | 0.050 |
Why?
|
Faculty | 1 | 2020 | 15 | 0.050 |
Why?
|
Rotator Cuff | 1 | 2000 | 67 | 0.050 |
Why?
|
Ultrasonography, Doppler | 1 | 2019 | 18 | 0.050 |
Why?
|
Disease-Free Survival | 1 | 2020 | 281 | 0.050 |
Why?
|
Quality Control | 1 | 2019 | 38 | 0.040 |
Why?
|
Calibration | 1 | 2019 | 25 | 0.040 |
Why?
|
Pubic Bone | 1 | 2019 | 2 | 0.040 |
Why?
|
Job Satisfaction | 1 | 2020 | 37 | 0.040 |
Why?
|
Educational Measurement | 1 | 2020 | 111 | 0.040 |
Why?
|
Femur | 2 | 2015 | 67 | 0.040 |
Why?
|
Range of Motion, Articular | 2 | 2017 | 177 | 0.040 |
Why?
|
Prospective Studies | 4 | 2000 | 2021 | 0.040 |
Why?
|
Thigh | 1 | 2019 | 39 | 0.040 |
Why?
|
Spinal Diseases | 1 | 1999 | 17 | 0.040 |
Why?
|
Reference Values | 2 | 2014 | 224 | 0.040 |
Why?
|
Peroneal Nerve | 2 | 2015 | 15 | 0.040 |
Why?
|
Tibial Nerve | 2 | 2015 | 16 | 0.040 |
Why?
|
Osteitis Deformans | 1 | 1998 | 2 | 0.040 |
Why?
|
Equipment Design | 1 | 2019 | 167 | 0.040 |
Why?
|
Low Back Pain | 1 | 1999 | 43 | 0.040 |
Why?
|
Neoplasm Staging | 1 | 2020 | 436 | 0.040 |
Why?
|
Weight Gain | 1 | 2019 | 108 | 0.040 |
Why?
|
Ankle Injuries | 1 | 2018 | 20 | 0.040 |
Why?
|
Granuloma Annulare | 1 | 1998 | 2 | 0.040 |
Why?
|
Shoulder Joint | 1 | 2000 | 123 | 0.040 |
Why?
|
Cysts | 1 | 1998 | 16 | 0.040 |
Why?
|
Body Fluids | 1 | 1998 | 6 | 0.040 |
Why?
|
Edema | 1 | 1998 | 30 | 0.040 |
Why?
|
Survival Rate | 1 | 2020 | 795 | 0.040 |
Why?
|
Fluoroscopy | 1 | 2018 | 37 | 0.040 |
Why?
|
Health Status Indicators | 1 | 2018 | 67 | 0.040 |
Why?
|
Finite Element Analysis | 1 | 2018 | 80 | 0.040 |
Why?
|
Myositis Ossificans | 1 | 1997 | 2 | 0.040 |
Why?
|
Logistic Models | 1 | 2020 | 727 | 0.040 |
Why?
|
Body Weight | 1 | 2019 | 290 | 0.040 |
Why?
|
Foot Diseases | 1 | 1997 | 7 | 0.040 |
Why?
|
Physical Examination | 1 | 2017 | 82 | 0.040 |
Why?
|
Hamartoma | 1 | 1997 | 11 | 0.040 |
Why?
|
Software | 1 | 2017 | 109 | 0.040 |
Why?
|
Oxygen Consumption | 2 | 2009 | 138 | 0.040 |
Why?
|
Peripheral Nervous System Diseases | 1 | 1997 | 45 | 0.040 |
Why?
|
Incidence | 1 | 2020 | 1119 | 0.040 |
Why?
|
Geriatric Assessment | 2 | 2014 | 355 | 0.040 |
Why?
|
Diabetes Mellitus | 1 | 2019 | 368 | 0.040 |
Why?
|
Health Education | 1 | 1997 | 121 | 0.040 |
Why?
|
Academies and Institutes | 1 | 2015 | 5 | 0.030 |
Why?
|
Radiology Department, Hospital | 1 | 2015 | 4 | 0.030 |
Why?
|
Workflow | 1 | 2015 | 20 | 0.030 |
Why?
|
Comparative Effectiveness Research | 1 | 2015 | 23 | 0.030 |
Why?
|
Professional Practice | 1 | 2015 | 23 | 0.030 |
Why?
|
Diffusion of Innovation | 1 | 2015 | 29 | 0.030 |
Why?
|
Trauma Centers | 1 | 2016 | 84 | 0.030 |
Why?
|
Artifacts | 1 | 2015 | 38 | 0.030 |
Why?
|
Costs and Cost Analysis | 1 | 2015 | 88 | 0.030 |
Why?
|
Information Dissemination | 1 | 2015 | 42 | 0.030 |
Why?
|
Sural Nerve | 1 | 2015 | 22 | 0.030 |
Why?
|
Glioma, Subependymal | 1 | 1995 | 2 | 0.030 |
Why?
|
Cerebral Ventricle Neoplasms | 1 | 1995 | 5 | 0.030 |
Why?
|
Clinical Medicine | 1 | 2015 | 13 | 0.030 |
Why?
|
Forecasting | 1 | 2015 | 133 | 0.030 |
Why?
|
Respiration | 1 | 1994 | 26 | 0.030 |
Why?
|
Muscular Diseases | 1 | 1994 | 19 | 0.030 |
Why?
|
Diaphragm | 1 | 1994 | 46 | 0.030 |
Why?
|
Independent Living | 1 | 2014 | 78 | 0.030 |
Why?
|
Bone Resorption | 1 | 2013 | 13 | 0.030 |
Why?
|
Intra-Abdominal Fat | 1 | 2013 | 61 | 0.030 |
Why?
|
Time Factors | 1 | 2017 | 2001 | 0.030 |
Why?
|
Pilot Projects | 1 | 2014 | 469 | 0.030 |
Why?
|
Child, Preschool | 2 | 1998 | 1167 | 0.030 |
Why?
|
Medial Collateral Ligament, Knee | 2 | 2000 | 4 | 0.020 |
Why?
|
Bone Morphogenetic Protein 4 | 1 | 2009 | 13 | 0.020 |
Why?
|
Bone Morphogenetic Protein 2 | 1 | 2009 | 21 | 0.020 |
Why?
|
Principal Component Analysis | 1 | 2009 | 60 | 0.020 |
Why?
|
Calorimetry, Differential Scanning | 1 | 2009 | 10 | 0.020 |
Why?
|
Demography | 1 | 2009 | 104 | 0.020 |
Why?
|
Linkage Disequilibrium | 1 | 2009 | 192 | 0.020 |
Why?
|
Gadolinium | 2 | 2000 | 19 | 0.020 |
Why?
|
Area Under Curve | 1 | 2009 | 85 | 0.020 |
Why?
|
Glucose Tolerance Test | 1 | 2009 | 125 | 0.020 |
Why?
|
Regression Analysis | 1 | 2009 | 274 | 0.020 |
Why?
|
Analysis of Variance | 1 | 2009 | 454 | 0.020 |
Why?
|
Caloric Restriction | 1 | 2009 | 92 | 0.020 |
Why?
|
Europe | 1 | 2007 | 77 | 0.020 |
Why?
|
Syndrome | 1 | 2007 | 66 | 0.020 |
Why?
|
Hormone Replacement Therapy | 1 | 2007 | 86 | 0.020 |
Why?
|
Overweight | 1 | 2009 | 256 | 0.020 |
Why?
|
Belgium | 1 | 2006 | 1 | 0.020 |
Why?
|
Rome | 1 | 2006 | 2 | 0.020 |
Why?
|
History, Ancient | 1 | 2006 | 6 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2008 | 641 | 0.020 |
Why?
|
Tomography, Emission-Computed | 1 | 2006 | 25 | 0.020 |
Why?
|
Estrogens | 1 | 2007 | 162 | 0.020 |
Why?
|
Blood Glucose | 1 | 2009 | 466 | 0.020 |
Why?
|
Subcutaneous Fat, Abdominal | 1 | 2006 | 13 | 0.020 |
Why?
|
Cell Size | 1 | 2006 | 32 | 0.020 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2008 | 464 | 0.020 |
Why?
|
Cholesterol, LDL | 1 | 2006 | 157 | 0.020 |
Why?
|
Plasminogen Activator Inhibitor 1 | 1 | 2005 | 46 | 0.020 |
Why?
|
Cross-Over Studies | 1 | 2005 | 94 | 0.020 |
Why?
|
Walking | 1 | 2006 | 177 | 0.020 |
Why?
|
Viscera | 1 | 2005 | 17 | 0.020 |
Why?
|
Waist-Hip Ratio | 1 | 2005 | 33 | 0.020 |
Why?
|
Case-Control Studies | 1 | 2007 | 859 | 0.020 |
Why?
|
Activities of Daily Living | 1 | 2006 | 240 | 0.020 |
Why?
|
Solubility | 1 | 2004 | 38 | 0.020 |
Why?
|
Serum | 1 | 2004 | 20 | 0.020 |
Why?
|
Pericardium | 1 | 2005 | 50 | 0.020 |
Why?
|
Bone Cysts | 1 | 2004 | 4 | 0.020 |
Why?
|
Osteolysis | 1 | 2004 | 7 | 0.020 |
Why?
|
Interleukin-6 | 1 | 2005 | 225 | 0.020 |
Why?
|
Sequence Analysis, DNA | 1 | 2004 | 139 | 0.020 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2004 | 152 | 0.020 |
Why?
|
Double-Blind Method | 1 | 2005 | 503 | 0.020 |
Why?
|
Promoter Regions, Genetic | 1 | 2004 | 212 | 0.010 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 1 | 2004 | 40 | 0.010 |
Why?
|
Polymorphism, Genetic | 1 | 2004 | 196 | 0.010 |
Why?
|
African Continental Ancestry Group | 1 | 2004 | 350 | 0.010 |
Why?
|
Diet | 1 | 2005 | 355 | 0.010 |
Why?
|
Smoking | 1 | 2005 | 427 | 0.010 |
Why?
|
Fascia | 1 | 2000 | 9 | 0.010 |
Why?
|
Arthrography | 1 | 2000 | 9 | 0.010 |
Why?
|
Rupture, Spontaneous | 1 | 2000 | 18 | 0.010 |
Why?
|
Rupture | 1 | 2000 | 29 | 0.010 |
Why?
|
Image Enhancement | 1 | 2000 | 70 | 0.010 |
Why?
|
Electrocardiography | 1 | 2005 | 568 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2006 | 3101 | 0.010 |
Why?
|
Connective Tissue | 1 | 1998 | 4 | 0.010 |
Why?
|
Buttocks | 1 | 1998 | 5 | 0.010 |
Why?
|
Osteoarthritis | 1 | 1998 | 74 | 0.010 |
Why?
|
Median Nerve | 1 | 1997 | 44 | 0.010 |
Why?
|
Skin | 1 | 1998 | 203 | 0.010 |
Why?
|
Hypertension | 1 | 2000 | 910 | 0.010 |
Why?
|